Contact number
(020) 7184 7000About
Provided by Dechert LLP
It takes many years to build a good reputation, and only one sudden, adverse incident or rogue employee to tarnish it. A corporate crisis may be largely unpreventable, but the response to the events and strategic advice will mitigate the short- and long-term consequences to the organization.
Dechert serves as a trusted business adviser to clients facing complex, high-profile crises. We have advised our clients through some of the largest and most complicated reputational threatening events in the last three decades. Our deep bench of experienced lawyers guides our clients through adversity, handling crises such as global cybersecurity attacks, ransom demands for data or personnel, government raids, employee theft and malfeasance, company threatening product recalls, senior management scandals, shareholder activism and hostile takeovers, geopolitical crises, natural disasters, OFAC sanctions, terrorist attacks, and more.
Our global crisis team provides the leadership and steady oversight not only to proactively navigate the criminal, civil, and regulatory issues that may result, but on all aspects of the crisis – from communicating with stakeholders and the media to advising on steps to avoid future liability. From the boardroom to the courtroom to the court of public opinion, Dechert’s team will be with you from the very start, helping to devise and implement crisis and communications plans to mitigate short-term and long-term risks.
Chambers Review
Dechert serves as a trusted business adviser to clients facing complex, high-profile crises. Its bench includes former US Attorneys, former senior lawyers from government agencies, seasoned litigators, cybersecurity experts and corporate strategists.
Andrew J. Levander, Clare Putnam Pozos, Brenda R. Sharton, Maria Sit and Hartley M.K. West are key contacts for this practice.
Work Highlights
- Dechert represents GlaxoSmithKline in multidistrict and state court litigation in the US relating to its Zantac heartburn medication. Plaintiffs allege that the medication causes cancer as a result of the formation of the chemical NDMA.